Tebra vs Elation Health

Side-by-side comparison of model-estimated upside.

Tebra

+21%

est. 2Y upside i

Healthcare

Rank

#2883

Sector

HealthTech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Tebra operates in a large and growing HealthTech market with $250M in revenue and profitability, which are strong fundamentals.

Last updated: March 10, 2026

Elation Health

+2%

est. 2Y upside i

HealthcareSeries D+

Rank

#3572

Sector

Healthcare

Est. Liquidity

~2Y

Data Quality

Data: Low

Elation Health is a structurally interesting but high-risk equity bet at its current $395M secondary valuation.

Last updated: May 5, 2026

Note: These companies have different risk levels. Tebra (Moderate Risk) and Elation Health (Higher Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.

Upside Comparison

Expected Upside

Tebra

+21%

Elation Health

+2%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.